IRWD
Ironwood Pharmaceuticals Inc
NASDAQ: IRWD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.15
-1.19% today
Updated 2026-04-29
Market cap
$658.76M
P/E ratio
26.93
P/S ratio
2.22x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$1 – $6
Volume
2.8M
Ironwood Pharmaceuticals Inc (IRWD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.15
12-Month target
$3.94
2030 Target
$2.48
Intrinsic (DCF)
$28.51
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -5.33% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 8.11%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.